Collaboration ATC. Life expectancy of individuals on combination antiretroviral therapy in high-income countries: a collaborative analysis of 14 cohort studies. The Lancet. 2008;372:293–9.
Mocroft A, Brettle R, Kirk O, et al. Changes in the cause of death among HIV positive subjects across Europe: results from the EuroSIDA study. AIDS. 2002;16:1663–71.
CAS PubMed Article Google Scholar
Murphy SL, Xu J, Kochanek KD, Arias E. Mortality in the United States. NCHS Data Brief. 2017;2018:1–8.
Grinspoon S, Carr A. Cardiovascular risk and body-fat abnormalities in HIV-infected adults. N Engl J Med. 2005;352:48–62.
CAS PubMed Article Google Scholar
Lake JE, Currier JS. Metabolic disease in HIV infection. Lancet Infect Dis. 2013;13:964–75.
Shah AS, Stelzle D, Lee KK, et al. Global burden of atherosclerotic cardiovascular disease in people living with HIV: systematic review and meta-analysis. Circulation. 2018;138:1100–12.
PubMed PubMed Central Article Google Scholar
Hsue PY, Waters DD. Time to recognize HIV infection as a major cardiovascular risk factor. Am Heart Assoc. 2018;138:1113–5.
Carroll MD, Fryar CD, Nguyen DT and Statistics NCfH. Total and high-density lipoprotein cholesterol in adults: United States, 2015–2016. US Department of Health and Human Services, Centers for Disease Control and Prevention. 2017.
Rader DJ, Hovingh GK. HDL and cardiovascular disease. The Lancet. 2014;384:618–25.
Duran EK, Aday AW, Cook NR, Buring JE, Ridker PM, Pradhan AD. Triglyceride-rich lipoprotein cholesterol, small dense LDL cholesterol, and incident cardiovascular disease. J Am Coll Cardiol. 2020;75(17):2122–35. https://doi.org/10.1016/j.jacc.2020.02.059.
CAS Article PubMed PubMed Central Google Scholar
Soppert J, Lehrke M, Marx N, Jankowski J, Noels H. Lipoproteins and lipids in cardiovascular disease: from mechanistic insights to therapeutic targeting. Adv Drug Deliv Rev. 2020;159:4–33. https://doi.org/10.1016/j.addr.2020.07.019 (Epub 2020 Jul 27).
CAS Article PubMed Google Scholar
Varbo A, Benn M, Tybjærg-Hansen A, Jørgensen AB, Frikke-Schmidt R, Nordestgaard BG. Remnant cholesterol as a causal risk factor for ischemic heart disease. J Am Coll Cardiol. 2013;61(4):427–36. https://doi.org/10.1016/j.jacc.2012.08.1026 (Epub 2012 Dec 19).
CAS Article PubMed Google Scholar
Hokanson JE, Austin MA. Plasma triglyceride level is a risk factor for cardiovascular disease independent of high-density lipoprotein cholesterol level: a metaanalysis of population-based prospective studies. J Cardiovasc Risk. 1996;3:213–9.
CAS PubMed Article Google Scholar
Cardiovascular Disease: A Costly Burden for America Projections Through 2035 (pp. 6–11, Rep. No. American Heart Association CVD Burden Report). (2017). Washington, DC: The American Heart Association Office of Federal Advocacy.
Kuklina EV, Yoon PW, Keenan NL. Prevalence of coronary heart disease risk factors and screening for high cholesterol levels among young adults, United States, 1999–2006. The Annals of Family Medicine. 2010;8:327–33.
Lepor NE, Vogel RE. Summary of the third report of the national cholesterol education program adult treatment panel III. Rev Cardiovasc Med. 2019;2:160–5.
Hadigan C, Meigs JB, Corcoran C, et al. Metabolic abnormalities and cardiovascular disease risk factors in adults with human immunodeficiency virus infection and lipodystrophy. Clin Infect Dis. 2001;32:130–9.
CAS PubMed Article Google Scholar
Depairon M, Chessex S, Sudre P, et al. Premature atherosclerosis in HIV-infected individuals–focus on protease inhibitor therapy. AIDS. 2001;15:329–34.
CAS PubMed Article Google Scholar
Behrens G, Dejam A, Schmidt H, et al. Impaired glucose tolerance, beta cell function and lipid metabolism in HIV patients under treatment with protease inhibitors. AIDS. 1999;13:F63–70.
CAS PubMed Article Google Scholar
Carr A, Samaras K, Burton S, et al. A syndrome of peripheral lipodystrophy, hyperlipidaemia and insulin resistance in patients receiving HIV protease inhibitors. AIDS. 1998;12:F51–8.
CAS PubMed Article Google Scholar
Walli R, Herfort O, Michl GM, et al. Treatment with protease inhibitors associated with peripheral insulin resistance and impaired oral glucose tolerance in HIV-1-infected patients. AIDS. 1998;12:F167–73.
CAS PubMed Article Google Scholar
Périard D, Telenti A, Sudre P, et al. Atherogenic dyslipidemia in HIV-infected individuals treated with protease inhibitors. Circulation. 1999;100:700–5.
Capeau J, Bouteloup V, Katlama C, et al. Ten-year diabetes incidence in 1046 HIV-infected patients started on a combination antiretroviral treatment. AIDS. 2012;26:303–14.
CAS PubMed Article Google Scholar
Waters DD, Hsue PY. Lipid abnormalities in persons living with HIV infection. Can J Cardiol. 2019;35:249–59.
Roth GA, Johnson CO, Abate KH, et al. The burden of cardiovascular diseases among US states, 1990–2016. JAMA Cardiol. 2018;3:375–89.
PubMed PubMed Central Article Google Scholar
Reif SS, Whetten K, Wilson ER, et al. HIV/AIDS in the Southern USA: a disproportionate epidemic. AIDS Care. 2014;26:351–9.
Reif S, Safley D, McAllaster C, Wilson E, Whetten K. State of HIV in the US Deep South. J Community Health. 2017;42:844–53.
Definitions S. Final dispositions of case codes and outcome rates for surveys. The American Association for Public Opinion Research. 2011.
Heeringa SG, West BT, Berglund PA. Applied survey data analysis. Boca Raton: Chapman and Hall/CRC; 2017.
Control CfD and Prevention. Vital signs: binge drinking prevalence, frequency, and intensity among adults-United States, 2010. MMWR Morb Mortal Wkly Rep. 2012;61:14.
Kroenke K, Strine TW, Spitzer RL, Williams JB, Berry JT, Mokdad AH. The PHQ-8 as a measure of current depression in the general population. J Affect Disord. 2009;114:163–73.
Armah K, Justice A, Oursler K, et al. The impact of elevated and prehypertensive systolic blood pressure and the risk of acute myocardial infarction in HIV+ and HIV-veterans. 19th Conference on Retroviruses and Oppotunistic Infections CROI. 2012.
Glass T, Ungsedhapand C, Wolbers M, et al. Prevalence of risk factors for cardiovascular disease in HIV-infected patients over time: the Swiss HIV Cohort Study. HIV Med. 2006;7:404–10.
CAS PubMed Article Google Scholar
American Diabetes Association. https://www.diabetes.org/diabetes/a1c/diagnosis. Accessed 23 May 2022.
Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, Jones DW, Materson BJ, Oparil S, Wright JT Jr, Roccella EJ, National Heart, Lung, and Blood Institute Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure, National High Blood Pressure Education Program Coordinating Committee. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA. 2003;289(19):2560–72. https://doi.org/10.1001/jama.289.19.2560 (Epub 2003 May 14. Erratum in: JAMA. 2003 Jul 9;290(2):197).
CAS Article PubMed Google Scholar
Kaplan RC, Kingsley LA, Sharrett AR, et al. Ten-year predicted coronary heart disease risk in HIV-infected men and women. Clin Infect Dis. 2007;45:1074–81.
Cioe PA, Crawford SL, Stein MD. Cardiovascular risk-factor knowledge and risk perception among HIV-infected adults. J Assoc Nurses AIDS Care. 2014;25:60–9.
Friis-Møller N, Weber R, Reiss P, et al. Cardiovascular disease risk factors in HIV patients–association with antiretroviral therapy. Results from the DAD study. AIDS. 2003;17:1179–93.
Pernerstorfer-Schoen H, Jilma B, Perschler A, et al. Sex differences in HAART-associated dyslipidaemia. AIDS. 2001;15:725–34.
CAS PubMed Article Google Scholar
Blann AD, Farrell A, Picton A, McCollum CN. Relationship between endothelial cell markers and arterial stenosis in peripheral and carotid artery disease. Thromb Res. 2000;97:209–16.
CAS PubMed Article Google Scholar
Mandell BF, Calabrese LH. Infections and systemic vasculitis. Curr Opin Rheumatol. 1998;10:51–7.
CAS PubMed Article Google Scholar
Foulkes AS, Wohl DA, Frank I, et al. Associations among race/ethnicity, ApoC-III genotypes, and lipids in HIV-1-infected individuals on antiretroviral therapy. PLoS Med. 2006;3: e52.
PubMed PubMed Central Article CAS Google Scholar
Benjamin EJ, Virani SS, Callaway CW, et al. Heart disease and stroke statistics-2018 update: a report from the American Heart Association. Circulation. 2018;137: e67.
Appel SJ, Harrell JS, Deng S. Racial and socioeconomic differences in risk factors for cardiovascular disease among Southern rural women. Nurs Res. 2002;51:140–7.
Brown TT, Cole SR, Li X, et al. Antiretroviral therapy and the prevalence and incidence of diabetes mellitus in the multicenter AIDS cohort study. Arch Intern Med. 2005;165:1179–84.
De Wit S, Sabin CA, Weber R, et al. Incidence and risk factors for new-onset diabetes in HIV-infected patients: the Data Collection on Adverse Events of Anti-HIV Drugs (D: A: D) study. Diabetes Care. 2008;31:1224–9.
留言 (0)